Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Kymab secures $100 million series C funding

November 25, 2016

Funds will enable Kymab to advance its proprietary pipeline of first-in-class therapeutic human ...

Ingredients | R and D | Finance

JHL Biotech and ASLAN to partner on manufacturing services for ASLAN004

November 14, 2016

ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targ ...

Ingredients | R and D | Asia

Nordic Nanovector and Heidelberg Pharma collaborate to develop novel ADCs targeting leukaemias

October 31, 2016

Leukaemias are orphan diseases with a significant unmet medical need, applicable indications re ...

Ingredients | R and D | Finance

Lonza and Forty Seven announce strategic manufacturing agreement for immuno-oncology therapeutic antibody pipeline

October 20, 2016

Lonza will manufacture material at its Slough (UK) facility for Forty Sevenís ongoing and futur ...

Ingredients | Manufacturing and Equipment

Nordic Nanovector and LegoChem Biosciences collaborate to develop novel antibody-drug conjugates (ADCs) targeting leukaemias

October 11, 2016

Leukemias are orphan diseases with a significant unmet medical need, representing a growing mar ...

Ingredients | R and D | Asia

CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer

April 22, 2016

The antibodies target an overexpressed protein on the surface of some cancer cells, which is no ...

Ingredients | R and D

ProBioGen and Eucodis agree to commercialise a novel antibody drug conjugation technology

April 22, 2016

The one-step C-LiNK coupling technology will open up the development space for ADCs and represe ...

Ingredients | Drug Delivery | R and D | Finance